Please provide your email address to receive an email when new articles are posted on . Alcon intends to acquire Ivantis, the developer and manufacturer of the Hydrus microstent, according to a ...

The competition in the microinvasive glaucoma surgical (MIGS) space is certainly heating up after today’s news. FDA has given a nod to Ivantis’ Hydrus Microstent, which will undoubtedly compete ...

Please provide your email address to receive an email when new articles are posted on . The first patient has been enrolled in a trial investigating the stand-alone use of the Hydrus microstent in ...

Three years after Alcon pulled its CyPass Micro-Stent from the market due to safety concerns, the Novartis spinoff has found another glaucoma treatment device to take its place. The Hydrus Microstent ...